Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancer.
Autor: | Schneider, Charlotte A., Täger, Philipp, Hammes, Jochen, Fischer, Thomas, Drzezga, Alexander, Pfister, David, Heidenreich, Axel, Schmidt, Matthias |
---|---|
Zdroj: | NuclearMedicine / Nuklearmedizin; Feb2022, Vol. 61 Issue 1, p25-32, 8p |
Databáze: | Complementary Index |
Externí odkaz: |